Abstract: Bioorthogonal reactions are widely used for the chemical modification of biomolecules.T he application of vinylboronic acids (VBAs) as non-strained, synthetically accessible and water-soluble reaction partners in ab ioorthogonal inverse electron-demand Diels-Alder (iEDDA) reaction with 3,6-dipyridyl-s-tetrazines is described. Depending on the substituents,VBA derivatives give second-order rate constants up to 27 m À1 s À1 in aqueous environments at room temperature, which is suitable for biological labeling applications.T he VBAs are shown to be biocompatible,n on-toxic, and highly stable in aqueous media and cell lysate.F urthermore,V BAs can be used orthogonally to the strain-promoted alkyne-azide cycloaddition for protein modification, making them attractive complements to the bioorthogonal molecular toolbox.
Inthe last decades,t he development of selective reactions between two reactants that are unaffected by any of the naturally occurring biological functionalities has been amajor research area in chemical biology. [1] These bioorthogonal reactions ( Figure 1A )m ake it possible to chemically modify biomolecules in their native cellular environment and gain ab etter understanding of their role in as pecific biological system or process.The bioorthogonal reaction should be high yielding and rapid, and the reactants and product(s) should be soluble and stable in aqueous media and non-toxic to the biological system. Theu se of small reactants is preferred to minimize steric interactions with the biomolecule or to facilitate incorporation by the endogenous cellular machinery.
TheCarboni-Lindsey (CL) reaction between an electronpoor tetrazine ( Figure 1B, I )a nd an alkene has gained considerable attention for use in bioorthogonal applications. [2] As linear and unmodified alkenes (Figure 1B, VI)s howed only poor reaction rates with tetrazines, [3] most research has been directed to the development and use of strained alkenes such as trans-cyclooctene (TCO), [4] norbornene, [5] cyclopropene, [6] or N-acylazetine [7] ( Figure 1B , II-V). In addition to strain, the rate of the CL reaction can be significantly enhanced by the introduction of electron-donating substituents on the alkene bond. [8] This aspect, however,h as been poorly investigated in relation to bioorthogonal applications.
Vinylboronic acids ( Figure 1B , VII)a re an interesting class of compounds with unique electronic properties,w hich are due to their vacant p-orbital. As aresult of the inductive effect that is caused by the electronegativity difference of boron and carbon, the electronic deficiencyofboron and the electron-donating oxygens attached to boron, boronic acid is considered to be aw eak electron-donor. [9] Furthermore, boronic acids are mild organic Lewis acids,w hich in basic aqueous media are in equilibrium with their boronate anion ( Figure 1B, VIII) , which is as trong electron-donor. [9] Although Diels-Alder reactions are known to proceed faster in aqueous media, the CL reactions of vinylboronic acids and alkylboronic acids are reported only in organic solvents,a nd high temperatures were often needed for the reaction to proceed. [10] In our effort to investigate the electronic effects of the alkenes in the CL reaction, we found that vinylboronic acids (VBAs) show impressive reaction rates with 3,6-dipyridiyl-stetrazines in aqueous environments.H erein, we evaluate VBAs as synthetically accessible,fast reacting bioorthogonal reaction partners with 3,6-dipyridyl-s-tetrazines.W es how that VBAs are stable,non-toxic, and can be used for protein labeling in vitro and in cell lysate.T he hydrophilic properties and the small size of VBAs make them attractive for use in protein modifications and other biomolecular labeling applications.
To explore the potential of VBAs as bioorthogonal reaction partners,w ef irst examined the second-order rate constants (k 2 )o f3 ,6-dipyridyl-s-tetrazine derivative 1 with several VBAs in 5% MeOH in PBS (Table 1a nd the Supporting Information, Figures S1 and 2) and compared them to the k 2 of norbornene 2,areagent that is used extensively in bioconjugation reactions. [2, 5] Vinylboronic acid 3 reacted with tetrazine 1 with ar ate of 3.0 m À1 s
À1
,w hich is comparable to the rate of 1 with norbornene 2.Amethyl substituent on the alkene reduced the reaction rate,although the rate of the (Z)-isomer was almost 3-fold faster than that of the (E)-isomer of 4.A ddition of ap henyl ring to the VBA increased the k 2 significantly,( E)-phenylvinylboronic acid 5 showed af ive-fold higher rate constant than norbornene 2, comparable to the reported rate constant of the fastest cyclopropene. [6] Fort his alkene,t he (Z)-isomer of 5 showed alower rate constant than (E)-5.Introduction of an electrondonating substituent on the phenyl ring of 8 increased the rate constant further to 27 m À1 s À1 . To evaluate the effect of the boronic acid on the alkenes reactivity,wecompared the rate constants of the fastest VBAs (E)-5 and 8 to the alkene derivatives lacking the boronic acid (Table 1 , Entries 4a nd 5). Under the selected conditions,w e could estimate adecrease in reaction rate of styrene 6 and pmethoxystyrene 9 of at least two orders of magnitude, although because of the reduced reaction rate and low solubility of the unsubstituted alkene in the aqueous environment, we could not determine the k 2 accurately.Introduction of an electron-donating alkoxy substituent on the alkene as in b-methoxystyrene 7 did not result in as ignificant increase in reaction rate,c learly indicating that the boronic acid has alarge positive effect on the reactivity of the alkene.Asimilar trend in the rate constants of the alkenes 2-9 with 3,6-dipyridyl-s-tetrazine 10 was observed in 50 %M eOH/PBS, although the constants decreased significantly in these less aqueous conditions (Supporting Information, Table S1 and Figures S3 and 4) .
Ther eactions of VBAs 3,( E)-5,a nd 8 were additionally studied with 3-phenyl-s-tetrazine and 3-phenyl-6-methyl-stetrazine (Supporting Information, Figure S5 ). Interestingly, compared to the reaction rate of these tetrazines with norbornene 2,t he reactions of the VBAs with the tetrazines are much slower than expected, which shows that the VBAs are especially suitable in the CL reactions with dipyridyl-stetrazines.
We then studied the reaction of 3,6-dipyridyl-s-tetrazine 10 and the most reactive VBA 8 in more detail (Figure 2A) . We observed quantitative formation of dihydropyradizine 11 as the most abundant isomer,w hich lacked the boronic acid. No intermediates were observed in the 1 HNMR spectra during the reaction between 10 and 8,w hich shows that the protodeborylation of boric acid is fast ( Figure 2B and the Supporting Information, Figure S6 ). We therefore propose amechanism in which boric acid is released immediately after the iEDDAc ycloaddition, followed by dinitrogen release by ar etro-Diels-Alder reaction ( Figure 2C ). Thed ihydropyridazine product 11 is the same as found in the reaction of tetrazine 10 with p-methoxystyrene 9 (Supporting Information, experimental section), [11] and slow isomerization and oxidization to the pyridazine product [8b] were observed by 1 HNMR and UV/Vis absorption (Supporting Information, Figures S7-9) .
Next, we examined the biocompatibility of the VBAs using the most reactive alkene 8.I nt he presence of most common functional groups such as amines,a lcohols,c arboxylic acids,a nd thiols, 8 was stable for at least seven days as observed by 1 HNMR (Supporting Information, Figure S10 ). Additionally,w ei ncubated VBA 8 in cell lysate up to 24 h before addition of tetrazine 1 and observed only marginal changes in the reaction rate,which indicates that 8 was stable in the presence of all biomolecules in the cells (Supporting Information, Figure S11 ). Forp ossible future applications of VBAs in live cells,w ea ssessed the toxicity of VBA 8, tetrazine 1,b oric acid, the side product of the CL reaction, and the dihydropyridazine product on NIH-3T3 cells.N o toxicity was observed after 24 hf or concentrations up to 100 mm for VBA 8 and boric acid, whereas tetrazine 1 and the dihydropyrazine product showed some toxicity at this concentration after 24 h( Supporting Information, Figure S12) .
TheC Lr eaction between VBAs and 3,6-dipyridiyl-stetrazine was next evaluated for its use for in vitro protein modification. Vinylboronic acids can be easily synthesized as the protected ester in one step by,f or example,c rossmetathesis between an alkene and av inylboronic ester [12] or hydroboration of an alkyne. [13] Hydrolysis of the boronic ester occurs spontaneously in aqueous media, although many deprotection strategies to the boronic acid are also available. [9] Forthe uniformity of this work, we initially synthesized the azide-containing VBA-probe 13,containing afree boronic acid ( Figure 3A and the Supporting Information, experimental section), which was obtained by hydroboration of aphenylacetylene derivative followed by removal of the ester through the conversion and hydrolysis of the organotrifluoroborate.
We equipped am odel protein human serum albumin (HSA), which contained one free cysteine,with adibenzocyclooctyl (DBCO) function using commercially available DBCO-maleimide 12 ( Figure 3B and the Supporting Information, Figure S13 ). TheHSA-DBCO was then reacted with 13,demonstrating that VBAs can be used orthogonally to the strain-promoted alkyne-azide cycloaddition (SPAAC) between aD BCO and an azide function. Notably,t he VBA is not orthogonal to aC u I -mediated reaction between an azide and an alkyne owing to copper-mediated boronic acid degradation. [14] We used tetrazine-BODIPY probe 16 (Figure 3A and the Supporting Information, experimental section) to visualize the VBA-modified HSA protein. Complete conversion to the dihydropyridazine (HSA-DHP) product was observed by mass spectrometry (Supporting Information, Figure S14 ), and the appearance of ag reen fluorescent band was observed by fluorescence imaging of the SDS-PAGEgel (Figure 3C,a) .
As boronic esters are more synthetically accessible than the free boronic acids,w ee valuated the stability of the pinacol boronic ester of 13 in aqueous media. Pinacol boronic ester 14 hydrolyzed to the boronic acid in PBS within 15 min (Supporting Information, Figure S15 ). We observed similar labeling results as with the free boronic acid 13,which shows the suitability of vinylboronic esters as VBAp recursors (Supporting Information, Figure S16 ). Additionally,w es ynthesized the VBAprecursor 15,which contained amaleimide for direct labeling of HSA. With VBA-maleimide 15,similar labeling intensities were observed after the CL reaction with 16 as in the two-step approach described above using the SPAACreaction (Supporting Information, Figure S17) .
We evaluated the rate of the CL reaction and the stability of the HSA-VBAp rotein in cell lysate.R eaction of HSAVBAw ith 10 equivalents tetrazine-BODIPY probe 16 provided ac lear fluorescent signal on aS DS-PAGEg el within 5min ( Figure 3C,b) . Forthis experiment we incubated HSAVBAwith 16 for the indicated time points before addition of a1 00-fold excess of non-fluorescent tetrazine 10, which accounts for the faint band observed at 0min. In addition, incubation of 1% HSA-VBA( 0.5 mm)i nc ell lysate (1 mg mL À1 )b efore the addition of the tetrazine-BODIPY probe 16 did not result in asignificant loss of signal after 24 h ( Figure 3C,c ) , which confirms the high stability of VBAs in the presence of biomolecules.F inally,adilution series of HSA-VBAi nc ell lysate showed that we could visualize the modified HSA protein by fluorescence imaging in concentrations up to 50 nm.Atthis concentration, aclear HSA band could no longer be distinguished on the gel when stained with Coomassie ( Figure 3C,d) , indicating the sensitivity of the CL reaction under these conditions. In summary,wehave shown the use of vinylboronic acids as novel class of bioorthogonal reactants with 3,6-dipyridyl-stetrazines in an iEDDAreaction. Although boron-containing organic compounds are rarely found in nature,t hey are extremely suitable for chemical biological applications due to their hydrophilicity,s tability,a nd low toxicity.T heir use in cellular systems has increased over the past years as,f or example,aprotease inhibitor, [15] biosensor, [16] fluorescent sensor, [17] activating reagent [18] or reactant in am etal-catalyzed bioconjugation reaction. [19] Herein, we add VBAs as bioorthogonal reactants to the molecular toolbox. While the reaction rates of tetrazines with TCO [4] are still orders of magnitude faster, the use of VBAs may be advantageous due to their chemical properties,s tability,a nd accessibility,w hile showing suitable rate constants that are required for modification and conjugation of biomolecules.
